Alterations in tumor biomarker GSTP gene methylation patterns induced by prenatal exposure to PFOS

Toxicology

Volumn 274, Issue 1-3, 2010, Pages 57-64

  Wan, Yan jian ^a   Li, Yuan yuan ^a   Xia, Wei ^a   Chen, Jun ^a   Lv, Zi quan ^a   Zeng, Huai cai ^a   Zhang, Ling ^a   Yang, Wen jie ^a   Chen, Tian ^a   Lin, Yi ^a   Wei, Jie ^a   Xu, Shun qing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

DNA methylation; GSTP; Perfluorooctane sulfonate; Prenatal; Rat

Indexed keywords

CYTOSINE; GLUTATHIONE TRANSFERASE P1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; PERFLUOROOCTANESULFONIC ACID; PROTEIN P16; TRANSCRIPTION FACTOR MAFK; TRANSCRIPTION FACTOR NRF2; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEEDING; FEMALE; GENE EXPRESSION; LIVER; LIVER TOXICITY; LIVER WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PERINATAL PERIOD; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROMOTER REGION; RAT; SPRAGUE DAWLEY RAT; TRANSCRIPTION REGULATION; UPREGULATION;

ALKANESULFONIC ACIDS; ANIMALS; BIOLOGICAL MARKERS; CARCINOGENS; DINUCLEOSIDE PHOSPHATES; DNA METHYLATION; FEMALE; FLUOROCARBONS; GENE EXPRESSION; GENES; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; LIVER; NEOPLASMS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SMOKING; TERATOGENS; THALIDOMIDE;

ANIMALIA; RATTUS;

EID: 77954144030     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.05.006     Document Type: Article

References (59)

1. Anglim P.P., Alonzo T.A., Laird-Offringa I.A. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. Mol. Cancer 2008, 7:81.
2. Bakker J., Lin X., Nelson W.G. Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells. J. Biol. Chem. 2002, 277:22573-22580.
3. Bogdanovic O., Veenstra G.J. DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma 2009, 118:549-565.
4. Brandeis M., Frank D., Keshet I., Siegfried Z., Mendelsohn M., Nemes A., Temper V., Razin A., Cedar H. Sp1 elements protect a CpG island from de novo methylation. Nature 1994, 371:435-438.
5. Brooks J., Cairns P., Zeleniuch-Jacquotte A. Promoter methylation and the detection of breast cancer. Cancer Causes Control 2009, 20:1539-1550.
6. Chouliaras L., Rutten B.P., Kenis G., Peerbooms O., Visser P.J., Verhey F., van Os J., Steinbusch H.W., van den Hove D.L. Epigenetic regulation in the pathophysiology of Alzheimer's disease. Prog. Neurobiol. 2010, 90:498-510.
7. Clark S.J., Harrison J., Paul C.L., Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 1994, 22:2990-2997.
8. Daniel V. Glutathione S-transferases: gene structure and regulation of expression. Crit. Rev. Biochem. Mol. Biol. 1993, 28:173-207.
9. Dinkova-Kostova A.T., Holtzclaw W.D., Cole R.N., Itoh K., Wakabayashi N., Katoh Y., Yamamoto M., Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:11908-11913.
10. Eads C.A., Laird P.W. Combined bisulfite restriction analysis (COBRA). Methods Mol. Biol. 2002, 200:71-85.
11. Esteller M., Corn P.G., Urena J.M., Gabrielson E., Baylin S.B., Herman J.G. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res. 1998, 58:4515-4518.
12. Fromme H., Tittlemier S.A., Volkel W., Wilhelm M., Twardella D. Perfluorinated compounds - exposure assessment for the general population in Western countries. Int. J. Hyg. Environ. Health 2009, 212:239-270.
13. Giesy J.P., Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ. Sci. Technol. 2001, 35:1339-1342.
14. Hales C.N., Barker D.J. The thrifty phenotype hypothesis. Br. Med. Bull. 2001, 60:5-20.
15. Harder J., Opitz O.G., Brabender J., Olschewski M., Blum H.E., Nomoto S., Usadel H. Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver. Int. J. Cancer 2008, 122:2800-2804.
16. Jeltsch A. Molecular enzymology of mammalian DNA methyltransferases. Curr. Top. Microbiol. Immunol. 2006, 301:203-225.
17. Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 2007, 8:253-262.
18. Kannan K., Franson J.C., Bowerman W.W., Hansen K.J., Jones P.D., Giesy J.P. Perfluorooctane sulfonate in fish-eating water birds including bald eagles and albatrosses. Environ. Sci. Technol. 2001, 35:3065-3070.
19. Karlseder J., Rotheneder H., Wintersberger E. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol. Cell. Biol. 1996, 16:1659-1667.
20. Kostka G., Urbanek K., Ludwicki J.K. The effect of phenobarbital on the methylation level of the p16 promoter region in rat liver. Toxicology 2007, 239:127-135.
21. Kovalenko V.M., Bagnyukova T.V., Sergienko O.V., Bondarenko L.B., Shayakhmetova G.M., Matvienko A.V., Pogribny I.P. Epigenetic changes in the rat livers induced by pyrazinamide treatment. Toxicol. Appl. Pharmacol. 2007, 225:293-299.
22. Kovesdi I., Reichel R., Nevins J.R. Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:2180-2184.
23. Krajinovic M., Ghadirian P., Richer C., Sinnett H., Gandini S., Perret C., Lacroix A., Labuda D., Sinnett D. Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions. Int. J. Cancer 2001, 92:220-225.
24. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99:366-394.
25. Lau C., Butenhoff J.L., Rogers J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol. Appl. Pharmacol. 2004, 198:231-241.
26. Lau C., Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Stanton M.E., Butenhoff J.L., Stevenson L.A. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II. Postnatal evaluation. Toxicol. Sci. 2003, 74:382-392.
27. Lin C.H., Hsieh S.Y., Sheen I.S., Lee W.C., Chen T.C., Shyu W.C., Liaw Y.F. Genome-wide hypomethylation in hepatocellular carcinogenesis. Cancer Res. 2001, 61:4238-4243.
28. Lin S.Y., Black A.R., Kostic D., Pajovic S., Hoover C.N., Azizkhan J.C. Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol. Cell. Biol. 1996, 16:1668-1675.
29. Luebker D.J., Case M.T., York R.G., Moore J.A., Hansen K.J., Butenhoff J.L. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 2005, 215:126-148.
30. Macleod D., Charlton J., Mullins J., Bird A.P. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 1994, 8:2282-2292.
31. Martin J.W., Kannan K., Berger U., de Voogt P., Field J., Franklin J., Giesy J.P., Harner T., Muir D.C., Scott B., Kaiser M., Jarnberg U., Jones K.C., Mabury S.A., Schroeder H., Simcik M., Sottani C., van Bavel B., Karrman A., Lindstrom G., van Leeuwen S. Analytical challenges hamper perfluoroalkyl research. Environ. Sci. Technol. 2004, 38:248A-255A.
32. Matsumoto M., Imagawa M., Aoki Y. Identification of an enhancer element of class pi glutathione S-transferase gene required for expression by a co-planar polychlorinated biphenyl. Biochem. J. 1999, 338(Pt 3):599-605.
33. Midasch O., Drexler H., Hart N., Beckmann M.W., Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int. Arch. Occup. Environ. Health 2007, 80:643-648.
34. Nakayama M., Gonzalgo M.L., Yegnasubramanian S., Lin X., De Marzo A.M., Nelson W.G. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer. J. Cell. Biochem. 2004, 91:540-552.
35. Nobori T., Miura K., Wu D.J., Lois A., Takabayashi K., Carson D.A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994, 368:753-756.
36. OECD (Organization for Economic Co-operation and Development), 2002. Co-operation on existing chemicals. Hazard assessment of perfluorooctane sulfonate (PFOS) and its salts, ENV/JM/RD(2002)17/FINAL, Paris.
37. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
38. Olivero-Verbel J., Tao L., Johnson-Restrepo B., Guette-Fernandez J., Baldiris-Avila R., O'Byrne-Hoyos I., Kannan K. Perfluorooctanesulfonate and related fluorochemicals in biological samples from the north coast of Colombia. Environ. Pollut. 2006, 142:367-372.
39. Phe V., Cussenot O., Roupret M. Methylated genes as potential biomarkers in prostate cancer. BJU Int. 2010.
40. Pogribny I.P., Tryndyak V.P., Boureiko A., Melnyk S., Bagnyukova T.V., Montgomery B., Rusyn I. Mechanisms of peroxisome proliferator-induced DNA hypomethylation in rat liver. Mutat. Res. 2008, 644:17-23.
41. Ramos-Gomez M., Kwak M.K., Dolan P.M., Itoh K., Yamamoto M., Talalay P., Kensler T.W. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:3410-3415.
42. Sakai M., Muramatsu M. Regulation of glutathione transferase P: a tumor marker of hepatocarcinogenesis. Biochem. Biophys. Res. Commun. 2007, 357:575-578.
43. Seacat A.M., Thomford P.J., Hansen K.J., Clemen L.A., Eldridge S.R., Elcombe C.R., Butenhoff J.L. Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicology 2003, 183:117-131.
44. Seacat A.M., Thomford P.J., Hansen K.J., Olsen G.W., Case M.T., Butenhoff J.L. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol. Sci. 2002, 68:249-264.
45. Smithwick M., Muir D.C., Mabury S.A., Solomon K.R., Martin J.W., Sonne C., Born E.W., Letcher R.J., Dietz R. Perflouroalkyl contaminants in liver tissue from East Greenland polar bears (Ursus maritimus). Environ. Toxicol. Chem. 2005, 24:981-986.
46. Steinmetz K.L., Pogribny I.P., James S.J., Pitot H.C. Hypomethylation of the rat glutathione S-transferase pi (GSTP) promoter region isolated from methyl-deficient livers and GSTP-positive liver neoplasms. Carcinogenesis 1998, 19:1487-1494.
47. Taniyasu S., Kannan K., Horii Y., Hanari N., Yamashita N. A survey of perfluorooctane sulfonate and related perfluorinated organic compounds in water, fish, birds, and humans from Japan. Environ. Sci. Technol. 2003, 37:2634-2639.
48. Tchou J.C., Lin X., Freije D., Isaacs W.B., Brooks J.D., Rashid A., De Marzo A.M., Kanai Y., Hirohashi S., Nelson W.G. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. Int. J. Oncol. 2000, 16:663-676.
49. Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Barbee B.D., Richards J.H., Butenhoff J.L., Stevenson L.A., Lau C. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I. Maternal and prenatal evaluations. Toxicol. Sci. 2003, 74:369-381.
50. Tryndyak V.P., Kovalchuk O., Muskhelishvili L., Montgomery B., Rodriguez-Juarez R., Melnyk S., Ross S.A., Beland F.A., Pogribny I.P. Epigenetic reprogramming of liver cells in tamoxifen-induced rat hepatocarcinogenesis. Mol. Carcinogen. 2007, 46:187-197.
51. Tseng C.L., Liu L.L., Chen C.M., Ding W.H. Analysis of perfluorooctanesulfonate and related fluorochemicals in water and biological tissue samples by liquid chromatography-ion trap mass spectrometry. J. Chromatogr. A 2006, 1105:119-126.
52. Verma M., Srivastava S. Epigenetics in cancer: implications for early detection and prevention. Lancet Oncol. 2002, 3:755-763.
53. Wang J., Qin Y., Li B., Sun Z., Yang B. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients. Clin. Biochem. 2006, 39:344-348.
54. Watson R.E., McKim J.M., Cockerell G.L., Goodman J.I. The value of DNA methylation analysis in basic, initial toxicity assessments. Toxicol. Sci. 2004, 79:178-188.
55. Xie Y., Liu J., Benbrahim-Tallaa L., Ward J.M., Logsdon D., Diwan B.A., Waalkes M.P. Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology 2007, 236:7-15.
56. Xiong Z., Laird P.W. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 1997, 25:2532-2534.
57. Yang A.S., Estecio M.R., Doshi K., Kondo Y., Tajara E.H., Issa J.P. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res. 2004, 32:e38.
58. Yang B., Guo M., Herman J.G., Clark D.P. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am. J. Pathol. 2003, 163:1101-1107.
59. Zhang Y.J., Wu H.C., Shen J., Ahsan H., Tsai W.Y., Yang H.I., Wang L.Y., Chen S.Y., Chen C.J., Santella R.M. Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA. Clin. Cancer Res. 2007, 13:2378-2384.